BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 27049382)

  • 21. Inhibition of the canonical Wnt pathway by high glucose can be reversed by parathyroid hormone-related protein in osteoblastic cells.
    López-Herradón A; Portal-Núñez S; García-Martín A; Lozano D; Pérez-Martínez FC; Ceña V; Esbrit P
    J Cell Biochem; 2013 Aug; 114(8):1908-16. PubMed ID: 23494914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. USP44 suppresses proliferation and enhances apoptosis in colorectal cancer cells by inactivating the Wnt/β-catenin pathway via Axin1 deubiquitination.
    Huang T; Zhang Q; Ren W; Yan B; Yi L; Tang T; Lin H; Zhang Y
    Cell Biol Int; 2020 Aug; 44(8):1651-1659. PubMed ID: 32285989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Positive feedback regulation between phospholipase D and Wnt signaling promotes Wnt-driven anchorage-independent growth of colorectal cancer cells.
    Kang DW; Min do S
    PLoS One; 2010 Aug; 5(8):e12109. PubMed ID: 20711340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lithium reduces tumorigenic potential in response to EGF signaling in human colorectal cancer cells.
    Vidal F; de Araujo WM; Cruz AL; Tanaka MN; Viola JP; Morgado-Díaz JA
    Int J Oncol; 2011 May; 38(5):1365-73. PubMed ID: 21369697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preclinical evaluation of destruxin B as a novel Wnt signaling target suppressing proliferation and metastasis of colorectal cancer using non-invasive bioluminescence imaging.
    Yeh CT; Rao YK; Ye M; Wu WS; Chang TC; Wang LS; Wu CH; Wu AT; Tzeng YM
    Toxicol Appl Pharmacol; 2012 May; 261(1):31-41. PubMed ID: 22465936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigation of lactate calcium salt-induced β-catenin destabilization in colorectal cancer cells.
    Jang YS; Sim JJ; Ji E; Jeong KY; Kim HM
    Life Sci; 2015 Oct; 139():160-5. PubMed ID: 26316447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenethyl isothiocyanate inhibits colorectal cancer stem cells by suppressing Wnt/β-catenin pathway.
    Chen Y; Li Y; Wang XQ; Meng Y; Zhang Q; Zhu JY; Chen JQ; Cao WS; Wang XQ; Xie CF; Li XT; Geng SS; Wu JS; Zhong CY; Han HY
    Phytother Res; 2018 Dec; 32(12):2447-2455. PubMed ID: 30159926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LGR5 regulates survival through mitochondria-mediated apoptosis and by targeting the Wnt/β-catenin signaling pathway in colorectal cancer cells.
    Hsu HC; Liu YS; Tseng KC; Tan BC; Chen SJ; Chen HC
    Cell Signal; 2014 Nov; 26(11):2333-42. PubMed ID: 25025569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Artesunate attenuates the growth of human colorectal carcinoma and inhibits hyperactive Wnt/beta-catenin pathway.
    Li LN; Zhang HD; Yuan SJ; Tian ZY; Wang L; Sun ZX
    Int J Cancer; 2007 Sep; 121(6):1360-5. PubMed ID: 17520675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CBB1003, a lysine-specific demethylase 1 inhibitor, suppresses colorectal cancer cells growth through down-regulation of leucine-rich repeat-containing G-protein-coupled receptor 5 expression.
    Hsu HC; Liu YS; Tseng KC; Yang TS; Yeh CY; You JF; Hung HY; Chen SJ; Chen HC
    J Cancer Res Clin Oncol; 2015 Jan; 141(1):11-21. PubMed ID: 25060070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct roles and differential expression levels of Wnt5a mRNA isoforms in colorectal cancer cells.
    Huang TC; Lee PT; Wu MH; Huang CC; Ko CY; Lee YC; Lin DY; Cheng YW; Lee KH
    PLoS One; 2017; 12(8):e0181034. PubMed ID: 28859077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.
    Lemieux E; Cagnol S; Beaudry K; Carrier J; Rivard N
    Oncogene; 2015 Sep; 34(38):4914-27. PubMed ID: 25500543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting of Wnt/β-Catenin by Anthelmintic Drug Pyrvinium Enhances Sensitivity of Ovarian Cancer Cells to Chemotherapy.
    Zhang C; Zhang Z; Zhang S; Wang W; Hu P
    Med Sci Monit; 2017 Jan; 23():266-275. PubMed ID: 28090074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ginsenoside Rg3 inhibits colorectal tumor growth through the down-regulation of Wnt/ß-catenin signaling.
    He BC; Gao JL; Luo X; Luo J; Shen J; Wang L; Zhou Q; Wang YT; Luu HH; Haydon RC; Wang CZ; Du W; Yuan CS; He TC; Zhang BQ
    Int J Oncol; 2011 Feb; 38(2):437-45. PubMed ID: 21152855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Berbamine suppresses cell proliferation and promotes apoptosis in ovarian cancer partially via the inhibition of Wnt/β-catenin signaling.
    Zhang H; Jiao Y; Shi C; Song X; Chang Y; Ren Y; Shi X
    Acta Biochim Biophys Sin (Shanghai); 2018 Jun; 50(6):532-539. PubMed ID: 29701777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Wnt/β-catenin signaling participates in cementoblast/osteoblast differentiation of dental follicle cells.
    Du Y; Ling J; Wei X; Ning Y; Xie N; Gu H; Yang F
    Connect Tissue Res; 2012; 53(5):390-7. PubMed ID: 22360497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of DK419, a potent inhibitor of Wnt/β-catenin signaling and colorectal cancer growth.
    Wang J; Mook RA; Ren XR; Zhang Q; Jing G; Lu M; Spasojevic I; Lyerly HK; Hsu D; Chen W
    Bioorg Med Chem; 2018 Nov; 26(20):5435-5442. PubMed ID: 30274939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emodin suppresses Wnt signaling in human colorectal cancer cells SW480 and SW620.
    Pooja T; Karunagaran D
    Eur J Pharmacol; 2014 Nov; 742():55-64. PubMed ID: 25205133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of oleandrin on the proliferation show and invasion of osteosarcoma cells in vitro by suppressing Wnt/β-catenin signaling pathway.
    Ma Y; Zhu B; Liu X; Yu H; Yong L; Liu X; Shao J; Liu Z
    J Exp Clin Cancer Res; 2015 Oct; 34():115. PubMed ID: 26444270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salinomycin inhibits metastatic colorectal cancer growth and interferes with Wnt/β-catenin signaling in CD133
    Klose J; Eissele J; Volz C; Schmitt S; Ritter A; Ying S; Schmidt T; Heger U; Schneider M; Ulrich A
    BMC Cancer; 2016 Nov; 16(1):896. PubMed ID: 27855654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.